419 related articles for article (PubMed ID: 26655717)
21. Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14.
Li Q; Shi L; Gui B; Yu W; Wang J; Zhang D; Han X; Yao Z; Shang Y
Cancer Res; 2011 Nov; 71(21):6899-908. PubMed ID: 21937684
[TBL] [Abstract][Full Text] [Related]
22. Cell cycle-specific function of Ikaros in human leukemia.
Li Z; Song C; Ouyang H; Lai L; Payne KJ; Dovat S
Pediatr Blood Cancer; 2012 Jul; 59(1):69-76. PubMed ID: 22106042
[TBL] [Abstract][Full Text] [Related]
23. Targeting High Dynamin-2 (DNM2) Expression by Restoring Ikaros Function in Acute Lymphoblastic Leukemia.
Ge Z; Gu Y; Han Q; Zhao G; Li M; Li J; Chen B; Sun T; Dovat S; Gale RP; Song C
Sci Rep; 2016 Nov; 6():38004. PubMed ID: 27885263
[TBL] [Abstract][Full Text] [Related]
24. Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia.
Ge Z; Song C; Ding Y; Tan BH; Desai D; Sharma A; Gowda R; Yue F; Huang S; Spiegelman V; Payne JL; Reeves ME; Iyer S; Dhanyamraju PK; Imamura Y; Bogush D; Bamme Y; Yang Y; Soliman M; Kane S; Dovat E; Schramm J; Hu T; McGrath M; Chroneos ZC; Payne KJ; Gowda C; Dovat S
Leukemia; 2021 May; 35(5):1267-1278. PubMed ID: 33531656
[TBL] [Abstract][Full Text] [Related]
25. MiR-137 inhibits cell proliferation in acute lymphoblastic leukemia by targeting JARID1B.
Huang Y; Zou Y; Zheng R; Ma X
Eur J Haematol; 2019 Sep; 103(3):215-224. PubMed ID: 31206203
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia.
Ge Z; Guo X; Li J; Hartman M; Kawasawa YI; Dovat S; Song C
Oncotarget; 2015 Dec; 6(39):42300-11. PubMed ID: 26517351
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic Regulation of Angiogenesis by JARID1B-Induced Repression of HOXA5.
Fork C; Gu L; Hitzel J; Josipovic I; Hu J; SzeKa Wong M; Ponomareva Y; Albert M; Schmitz SU; Uchida S; Fleming I; Helin K; Steinhilber D; Leisegang MS; Brandes RP
Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1645-52. PubMed ID: 26023081
[TBL] [Abstract][Full Text] [Related]
28. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
[TBL] [Abstract][Full Text] [Related]
29. Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases.
Horton JR; Engstrom A; Zoeller EL; Liu X; Shanks JR; Zhang X; Johns MA; Vertino PM; Fu H; Cheng X
J Biol Chem; 2016 Feb; 291(6):2631-46. PubMed ID: 26645689
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of JARID1B expression inhibits cell proliferation, induces apoptosis and blocks cell cycle in human acute lymphoblastic leukemia cells.
Huang YQ; Zou Y; Zheng RJ; Ma XD
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1366-1373. PubMed ID: 29565495
[TBL] [Abstract][Full Text] [Related]
31. Jumonji/ARID1 B (JARID1B) protein promotes breast tumor cell cycle progression through epigenetic repression of microRNA let-7e.
Mitra D; Das PM; Huynh FC; Jones FE
J Biol Chem; 2011 Nov; 286(47):40531-5. PubMed ID: 21969366
[TBL] [Abstract][Full Text] [Related]
32. Identification of small molecule inhibitors of Jumonji AT-rich interactive domain 1B (JARID1B) histone demethylase by a sensitive high throughput screen.
Sayegh J; Cao J; Zou MR; Morales A; Blair LP; Norcia M; Hoyer D; Tackett AJ; Merkel JS; Yan Q
J Biol Chem; 2013 Mar; 288(13):9408-17. PubMed ID: 23408432
[TBL] [Abstract][Full Text] [Related]
33. Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor.
Kuo KT; Huang WC; Bamodu OA; Lee WH; Wang CH; Hsiao M; Wang LS; Yeh CT
Clin Epigenetics; 2018 Aug; 10(1):107. PubMed ID: 30092824
[TBL] [Abstract][Full Text] [Related]
34. The multifaceted role of protein kinase CK2 in high-risk acute lymphoblastic leukemia.
Zhou Y; Lian H; Shen N; Korm S; Kwok Ping Lam A; Layton O; Huiting LN; Li D; Miao K; Zeng A; Landesman-Bollag E; Seldin DC; Fu H; Hong L; Feng H
Haematologica; 2021 May; 106(5):1461-1465. PubMed ID: 32817283
[No Abstract] [Full Text] [Related]
35. Elevated histone H3 acetylation and loss of the Sp1-HDAC1 complex de-repress the GM2-synthase gene in renal cell carcinoma.
Banerjee A; Mahata B; Dhir A; Mandal TK; Biswas K
J Biol Chem; 2019 Jan; 294(3):1005-1018. PubMed ID: 30463940
[TBL] [Abstract][Full Text] [Related]
36. Signaling pathways and regulation of gene expression in hematopoietic cells.
Bogush D; Schramm J; Ding Y; He B; Singh C; Sharma A; Tukaramrao DB; Iyer S; Desai D; Nalesnik G; Hengst J; Bhalodia R; Gowda C; Dovat S
Adv Biol Regul; 2023 May; 88():100942. PubMed ID: 36621151
[TBL] [Abstract][Full Text] [Related]
37. JARID1B modulates lung cancer cell proliferation and invasion by regulating p53 expression.
Shen X; Zhuang Z; Zhang Y; Chen Z; Shen L; Pu W; Chen L; Xu Z
Tumour Biol; 2015 Sep; 36(9):7133-42. PubMed ID: 25877751
[TBL] [Abstract][Full Text] [Related]
38. Androgen receptor activation by polychlorinated biphenyls: epigenetic effects mediated by the histone demethylase Jarid1b.
Casati L; Sendra R; Poletti A; Negri-Cesi P; Celotti F
Epigenetics; 2013 Oct; 8(10):1061-8. PubMed ID: 23907094
[TBL] [Abstract][Full Text] [Related]
39. Transcription factor Ikaros represses protein phosphatase 2A (PP2A) expression through an intronic binding site.
Nagpal K; Watanabe KS; Tsao BP; Tsokos GC
J Biol Chem; 2014 May; 289(20):13751-7. PubMed ID: 24692537
[TBL] [Abstract][Full Text] [Related]
40. Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor.
Kristensen LH; Nielsen AL; Helgstrand C; Lees M; Cloos P; Kastrup JS; Helin K; Olsen L; Gajhede M
FEBS J; 2012 Jun; 279(11):1905-14. PubMed ID: 22420752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
